Addiction Medicine Expert to Speak in Tulsa

Parkside Psychiatric Hospital & Clinic (Parkside) will host John F. Kelly, PhD, ABPP, from 8:30 a.m. to 3:15 p.m. on November 14 for professional education centered on addiction medicine, evidence-based practice for substance use disorders and related matters of policy and research. The event, which will take place in the Perkins Auditorium at the OU Schusterman Center, is now open for registration.


Parkside Psychiatric Hospital & Clinic (Parkside) will host John F. Kelly, PhD, ABPP, from 8:30 a.m. to 3:15 p.m. on November 14 for professional education centered on addiction medicine, evidence-based practice for substance use disorders and related matters of policy and research. The event, which will take place in the Perkins Auditorium at the OU Schusterman Center, is now open for registration. Cost is $109 and provides five continuing education units for mental health professionals and pharmacists. Students can purchase tickets for $79.

Dr. Kelly’s seminar, titled “Substance Use Disorder: 50 years of Policy, Research, and Treatment,” will cover government policy action and impact, changes and advancements in treatment during the past 50 years examining the clinical paradigm shifts that have occurred and a focus on current evidence-based treatments for addressing substance use and related problems.

Dr. John Kelly is the Associate Professor of Psychiatry in the Field of Addiction Medicine at Harvard Medical School. Dr. Kelly is also the founder and Director of the Recovery Research Institute at Massachusetts General and the Associate Director of the Center for Addiction Medicine. Dr. Kelly has served as a consultant to U.S. federal agencies including the White House Office of National Drug Control Policy and the Substance Abuse and Mental Health Services Administration (SAMHSA). He has published more than 140 peer-reviewed articles and currently works with Psychology Today magazine as a monthly contributor.

Parkside is a private, nonprofit, mental healthcare and substance abuse treatment provider offering inpatient and outpatient care to Oklahoma children, adolescents and adults. More information and registration is available at www.parksideinc.org.                  



Add a Comment

Latest Posts

  • COVID -19 updates: Parkside's Response and Recent Changes to Patient Visitation


    - Jul 22, 2020

    Parkside is following the evolving COVID-19 situation closely and is prepared for any needed response. Parkside always maintains a robust infection control program and is prepared for emergencies. We have adopted changes to patient visitation effective 7/20/2020. Here are some of the steps Parkside is taking to manage the COVID-19:

  • Parkside Response to COVID-19


    - Apr 09, 2020

    With confirmed cases of COVID-19 (Coronavirus) on the rise in Oklahoma and throughout the United States, Parkside is taking proactive steps to ensure the continued safety of our patients and staff. To reduce the spread of COVID-19, Parkside has implemented the following safety measures:

  • Parkside responds to the COVID -19 situation


    - Mar 17, 2020

    Parkside is following the evolving COVID-19 situation closely and is actively preparing for any needed response. Parkside always maintains a robust infection control program and is prepared for emergencies. Here are some of the steps Parkside is taking to manage the COVID-19:

  • Parkside Opens New Facility


    - Feb 05, 2020

    February 5, 2020 (Tulsa, OK) – Parkside Psychiatric Hospital & Clinic opened their new hospital this week that expands access to mental health care in Oklahoma. The new hospital, located at 1239 S. Trenton Ave., features 80 single-occupancy patient rooms for children, adolescents, and adults experiencing acute mental health crises.

  • Parkside to Host Open House at New Psychiatric Hospital


    - Dec 04, 2019

    Parkside Psychiatric Hospital & Clinic is offering a sneak peek of their new hospital that will increase access to mental health care in Oklahoma. Parkside’s community open house is scheduled for Monday, December 16 from 3:00 – 5:00 p.m.